Related Experiment Video
Updated: Aug 7, 2026

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
Published on: December 3, 2016
Interactions between growth hormone and dexamethasone in skeletal growth and bone structure of the young mouse
A Altman1, Z Hochberg, M Silbermann
1Department of Morphological Sciences, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa.
Abstract:
The present study investigated the interactions of growth hormone (GH) and glucocorticoid on skeletal growth and bone structure in young mice. The purpose of this study was to examine the possible prevention by GH of the damage inflicted by dexamethasone (Dex) at sites of skeletal growth and ossification. Dex (1 mg/kg) with or without rat GH (rGH) or bovine GH (bGH), 1 mg/kg, was given for 4 weeks, from age 3-7 weeks, to female ICR mice. Tibiae, humerus, and vertebrae were analyzed morphometrically and biochemically. Growth, as determined by the mouse weight, tibial length, and humerus protein content was found to be compromised by dexamethasone. This was prevented by rGH or bGH. The epiphyseal growth plate width, trabecular bone volume, cortical bone width, mineral bone content, and alkaline and acid phosphatase activity were decreased by dexamethasone. These were prevented by rGH or by bGH. The findings of the present study suggest that in the mouse, GH can decrease or even avoid some of the pathological features in growing bones inflicted by high-dose glucocorticoid treatment.
Insights
Growth hormone (GH) prevents bone damage caused by the steroid dexamethasone in young mice. GH treatment protected against reduced bone growth and structural integrity, preserving skeletal development.
Area of Science:
- Endocrinology
- Orthopedics
- Developmental Biology
Background:
- Glucocorticoids, like dexamethasone, are known to negatively impact skeletal growth and bone structure.
- Growth hormone (GH) plays a crucial role in longitudinal bone growth and skeletal development.
- Understanding the interplay between GH and glucocorticoids is essential for managing conditions affecting bone health in growing individuals.
Purpose of the Study:
- To investigate the protective effects of growth hormone (GH) against dexamethasone-induced damage in skeletal growth sites.
- To determine if GH can prevent the detrimental effects of glucocorticoids on bone morphometry and biochemistry in young mice.
Main Methods:
- Female ICR mice (3-7 weeks old) were administered dexamethasone (Dex) with or without rat GH (rGH) or bovine GH (bGH) for 4 weeks.
- Tibiae, humerus, and vertebrae were analyzed using morphometric and biochemical assessments.
- Key parameters measured included body weight, bone length, protein content, growth plate width, bone volume, and enzyme activities.
Main Results:
- Dexamethasone significantly compromised growth (body weight, tibial length, humerus protein) and bone structure (growth plate width, trabecular bone volume, cortical bone width, mineral content).
- Dexamethasone also decreased alkaline and acid phosphatase activity, indicating impaired bone metabolism.
- Co-administration of rGH or bGH effectively prevented these dexamethasone-induced negative effects on skeletal growth and bone parameters.
Conclusions:
- Growth hormone (GH) can mitigate or prevent the pathological changes in growing bones caused by high-dose glucocorticoid treatment in mice.
- These findings highlight the potential therapeutic role of GH in counteracting glucocorticoid-induced bone damage during development.
- GH's protective action on skeletal sites emphasizes its importance in maintaining bone health under conditions of steroid exposure.
Related Concept Videos
Nature and Nurture
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

